Asked by: John Healey (Labour - Wentworth and Dearne)
Question to the Ministry of Defence:
To ask the Secretary of State for Defence, how much funding his Department has (a) allocated to and (b) spent on the DragonFire programme.
Answered by James Cartlidge - Minister of State (Ministry of Defence)
The DragonFire Laser Directed Energy Weapons accelerated programme, announced in April 2024 by the Secretary of State for Defence, will see £350 million in government investment by April 2027 to deliver minimum deployable capability. The accelerated programme is based on the DragonFire technology demonstrator which has seen £100 million of joint investment from MOD and UK industry since 2017. With £50 million funded by MOD and an additional £50 million funded by industry partners. The MOD is committed to the continued investment in UK Sovereign DEW technology, to provide cutting edge capability to the Armed Forces at pace.
Asked by: Emily Thornberry (Labour - Islington South and Finsbury)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, with reference to her Department's publications entitled DSIT: spending over £500, October 2023 and DSIT: spending over £500, November 2023, published on 17 May 2024 for what reason payments of (a) £794.50 were made to Trove on 18 October 2023 and (b) £700 were made to Blue Orchid Hotels on 27 November 2023.
Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)
The Department spent a) £794.50 at Trove on catering for 70 people attending an all-day staff training event held off-site and b) £700 with Blue Orchid Hotels on the hire of a venue and equipment for an all-day staff training event for 100 people.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, further to the UK Radiotherapy Board report Recovering radiotherapy services in England: Our plan for action, published in May, what assessment they have made of the finding that "a relatively small increase in staff funding would make a big difference to patient care".
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Whilst no assessment has been made of this finding, the NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. It will put the workforce on a sustainable footing for the long term.
The Government is backing the LTWP with over £2.4 billion over the next five years, to fund additional education and training places. This is on top of increases to education and training investment, reaching a record total of £6.1 billion over the next two years. By significantly expanding domestic education, training, and recruitment, we will have more healthcare professionals working in the NHS. This will include more doctors and nurses, alongside an expansion in a range of other professions, including more staff working in new roles. The LTWP also commits to reform and modernise the way staff work, and harness new technology and innovations to increase productivity and make sure staff can spend more time with patients.
In January 2024 there were 35,252 full-time equivalent (FTE) staff in the cancer workforce, an increase of 60.7% since January 2010. This includes 8,142 FTE consultants in January 2024, an increase of 69.6% since January 2010. There are 3,144 FTE therapeutic radiographers working in NHS trusts and other core organisations in England. This is 4.3% more than in 2023, 14.6% more than in 2019, and 55.2% more than in 2010.
Asked by: Baroness Northover (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government when all mothers' health records will be digitalised and shared between all healthcare professionals to improve communications between health workers and mothers.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Currently all maternity services have the ability to create digital records, and the sharing of those records across all providers involved in the care of the individual is done by a platform called Connecting Care Records. Integrated care boards (ICBs) should share historical care records between National Health Service trusts and other providers of care within their system, such as general practices and local authorities.
By March 2025, many more Connecting Care Records platforms will be providing access to data held in other ICB shared systems, allowing authorised health and care professionals to have safe, secure access to patient data, where and when its needed, regardless of where the person resides or where the care is provided.
Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)
Question to the Home Office:
To ask His Majesty's Government what measures they are considering implementing to (1) monitor, and (2) evaluate the progress of the post-Brexit border strategy, and what steps they are taking to share new information with affected companies and organisations across the UK.
Answered by Lord Sharpe of Epsom - Parliamentary Under-Secretary (Home Office)
Progress against delivery of the 2025 UK Border Strategy can be seen through publication and subsequent implementation of the Border Target Operating Model (BTOM). This has enabled us to bring together policy and process improvements through better use of technology and data, most notably with the development of a Single Trade Window.
We have continued to explore innovation at the border through our Ecosystem of Trust Pilots. The BTOM also outlines our plans for improving border processes for exporters. The Government will continue to monitor progress on specific BTOM policies in line with Magenta Book guidance on evaluation.
The Government worked extensively with traders to ensure current and future changes at the border are clear and that they have ample time to prepare. Engagement with businesses has been extensive, including: 10,000 participants registering for Government-led events before final BTOM publication; regular contact with around 30,000 importers to provide up-to-date information; the delivery of over 50 webinars to thousands of businesses; engagement with major supermarkets and their suppliers to provide training, and communication to 150k businesses in the UK.
Asked by: Jess Phillips (Labour - Birmingham, Yardley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what flexibility (a) NICE and (b) NHS England have to approve for use drugs that (i) are used in combination with other drugs, (ii) are used for various (A) conditions and (B) lines of treatment and (iii) provide significant benefits for some but not all patients; and what tools those organisations use to ensure the effectiveness of such appraisals.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines, and significant licence extensions for existing medicines, should be routinely funded by the NHS. The NICE is able to recommend most new medicines for use by the NHS, including as a result of commercial agreements negotiated between NHS England and the company, in line with the commercial framework for new medicines.
The NICE develops its guidance in line with its published health technology evaluations manual, which sets out the circumstances in which its Appraisal Committees are able to apply flexibility in the evaluation of specific treatments. The NICE is, for example, able to apply a modifier in the evaluation of medicines for severe diseases that means that its committees are able to recommend medicines at a higher cost-effectiveness threshold than for less severe diseases. The NICE appraises combination therapies using the same methods that it uses for appraising single drug therapies.
Asked by: Marquess of Lothian (Conservative - Life peer)
Question to the Home Office:
To ask His Majesty's Government what estimate they have made of the amount of cocaine that arrived in the UK in (1) 2023, and (2) 2024 to date, as a result of Balkan drug gangs and their criminal networks; and what steps they are taking, together with European partners, to (a) end the illegal activities associated with Balkan drug dealers, and (b) disrupt the supply of cocaine across Europe.
Answered by Lord Sharpe of Epsom - Parliamentary Under-Secretary (Home Office)
Illegal drugs devastate lives, ruin families and damage communities. The Government is committed to tackling these harms, including drug-related gang activity.
a) Reducing the threat posed by transnational Western Balkans organised crime groups (WBOCGs) is a government priority. We intensified the cooperation with our international partners to maximise the impact of our interventions WBOCGs wherever they are. Our engagements have already resulted in strategic partnerships with countries such as France, Germany, Italy, and Albania. In addition, the National Crime Agency (NCA) has well established relationships with law enforcement partners across Europe, as well as with Europol and Interpol, which include regular exchanges on organised crime with links to the Western Balkans. We are also seeking to improve criminal records sharing arrangements and law enforcement cooperation between the UK and the Western Balkan countries.
b) Our ten-year Drug Strategy, From Harm to Hope, sets out a whole system approach to combat illicit drugs. As part of this the Home Office has committed £300m of dedicated investment over three years (April 2022 – March 2025) to tackle every phase of the drug supply chain and make it considerably harder for criminal gangs to operate. With this funding we are supporting intelligence-led approaches to interdict and seize drugs as they cross the UK border and prevent criminal groups from bringing drugs to our streets. Across the whole of the UK, the NCA, Border Force, and local police are working in partnership, using intelligence and technology to secure our borders against drug trafficking. We are also funding upstream activity to tackle overseas drug supply, which is aimed at disrupting the criminal networks seeking to traffic illegal drugs to the UK. This includes building close enforcement partnerships with law enforcement agencies in mainland Europe.
The NCA has estimated that the UK consumes 117 tonnes of cocaine each year. We do not hold data on the amount of cocaine arriving in the UK as a result of Balkan OCGs. In the financial year ending 2023, police and Border Force seized 18.58 tonnes of powder cocaine, the second largest quantity of the substance since records began.
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking with Ofcom to ensure that its guidance on age (a) verification and (b) assurance under the Online Safety Act 2023 reflects data privacy considerations.
Answered by Saqib Bhatti - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
The Online Safety Act 2023 includes strong safeguards for user privacy. The Act includes principles that Ofcom must have regard to when recommending the use of age assurance technologies for compliance with duties in the Act. Privacy has been represented in these principles, which outline that considerations relating to privacy, as set out in the Data Protection Act 2018, apply to all uses of age assurance technologies used to comply with duties in the Act.
Ofcom is consulting on its codes of practice and guidance, with the child safety codes of practice currently out for consultation.
Asked by: Lord Taylor of Warwick (Non-affiliated - Life peer)
Question to the Home Office:
To ask His Majesty's Government what steps they are taking to support businesses in understanding and navigating the changes to visa eligibility rules, particularly in sectors heavily reliant on international talent.
Answered by Lord Sharpe of Epsom - Parliamentary Under-Secretary (Home Office)
The Home Office regularly engages with a range of stakeholders across the labour, education and legal sector to ensure they understand any changes that the department are making to the immigration system.
The Government is encouraging all sectors to adapt and make employment more attractive to UK domestic workers through offering training, career options, wage increases and to invest in increased automation technology.
We keep all our immigration policies under constant review to ensure they best serve the UK and reflect the public’s priorities, including filling skills gaps and growing the economy.
Asked by: Baroness Verma (Conservative - Life peer)
Question to the HM Treasury:
To ask His Majesty's Government whether they have made an assessment of the regulatory regimes in (1) Singapore, (2) the United Arab Emirates, and (3) the European Union, in attracting the business of crypto and digital assets firms; and in doing so, whether they have identified any lessons to learn in seeking to establish the United Kingdom as a global crypto asset technology hub.
Answered by Baroness Vere of Norbiton - Parliamentary Secretary (HM Treasury)
Last year, the government published its final proposals for the financial services regulation of cryptoassets in the UK and is currently working on legislation to implement those proposals.
In progressing the UK’s regulatory framework for cryptoassets, the government has been closely engaged to both monitor developments in other jurisdictions, and to support thought leadership on cryptoassets in international fora such as the Financial Stability Board.
The Treasury also has regular economic and financial dialogues with partners such as Singapore and the European Union to share knowledge and discuss opportunities for cooperation in financial services, including cryptoassets regulation.